Integration of in vitro biorelevant dissolution and in vivo bioequivalence study to in silico PBPK modelling of furosemide oral formulations to predict bioequivalence in dogs by PBBM approach
canines (Bikdeli et al., 2013), however there is a lack of knowledge regarding the dose-exposure-response relationship and the impact of multi-source drug products with no bioequivalence evaluation ... intravenous and…

